Key Events This Week
16 Feb: Q3 FY26 results reveal revenue decline and margin pressure
17 Feb: Valuation metrics shift, signalling renewed price attractiveness
19 Feb: Sharp stock decline amid broader market weakness
20 Feb: Week closes at Rs.87.65, down 0.74% for the week

QMS Medical Allied Services Ltd is Rated Strong Sell
2026-02-19 10:11:15QMS Medical Allied Services Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
QMS Medical Allied Services Ltd: Valuation Shifts Signal Renewed Price Attractiveness
2026-02-17 08:04:48QMS Medical Allied Services Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive price range. This change, driven primarily by adjustments in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a potential reappraisal of the stock’s price attractiveness amid a challenging sector backdrop and mixed returns relative to the broader market.
Read full news article
QMS Medical Allied Services Q3 FY26: Revenue Decline and Margin Pressure Signal Operational Headwinds
2026-02-16 13:37:16QMS Medical Allied Services Ltd., a micro-cap medical products distributor with a market capitalisation of ₹180.00 crores, reported a challenging third quarter for FY2026, with consolidated net profit declining 23.08% quarter-on-quarter to ₹2.40 crores in Q3 FY26 from ₹3.12 crores in Q2 FY26. On a year-on-year basis, the profit contraction was even more pronounced at 17.81%, falling from ₹2.92 crores in Q3 FY25. The stock, trading at ₹92.75, has gained 5.04% in the latest trading session, though it remains 18.64% below its 52-week high of ₹114.00.
Read full news article
QMS Medical Allied Services Ltd Forms Death Cross, Signalling Bearish Trend
2026-02-09 18:00:34QMS Medical Allied Services Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development suggests a potential shift towards a bearish trend, reflecting deteriorating momentum and long-term weakness in the stock’s price action.
Read full news article
QMS Medical Allied Services Ltd is Rated Sell
2026-02-08 10:10:05QMS Medical Allied Services Ltd is rated Sell by MarketsMOJO, with this rating last updated on 04 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news articleWhy is QMS Medical Allied Services Ltd falling/rising?
2026-01-31 00:56:01
Short-Term Price Movement and Market Context
QMS Medical Allied Services Ltd outperformed its sector by 10.17% on the day, a notable achievement given the broader market conditions. Over the past week, the stock has gained 2.61%, surpassing the Sensex’s 1.09% rise. However, the one-month and year-to-date returns remain negative at -1.67% and -1.23% respectively, though these losses are less severe than the Sensex’s declines of -2.38% and -3.10% over the same periods. This suggests that while the stock has struggled recently, it is showing signs of relative resilience.
Technical indicators reveal that the current price is above the 5-day and 20-day moving averages, signalling short-term bullish momentum. However, it remains below the 50-day, 100-day, and 200-day average...
Read full news article
QMS Medical Allied Services Ltd is Rated Sell
2026-01-28 10:10:05QMS Medical Allied Services Ltd is rated Sell by MarketsMOJO. This rating was last updated on 04 Dec 2025, reflecting a shift from the previous Hold rating. However, the analysis and financial metrics discussed here represent the stock’s current position as of 28 January 2026, providing investors with the latest insights into its performance and outlook.
Read full news article






